Oncimmune Holdings PLC (LSE:ONC) - Share price


Stock Report

Oncimmune Holdings PLC ONC

Last Price
GBX119.50

Day Change
7.00|6.22%

As of 04/06/2020
17:15:00 BST | GBX
Minimum 15 Minutes Delay.

Last Close112.50p
Day Range115.30 - 120.90
Mkt Cap75.88Mil
52-Wk Range30.00 - 120.90
Yield %-
ISINGB00BYQ94H38
Volume2,980,098
P/E-
P/S4.31
P/CF-0.10

Share Price

Total Returns 04/06/2020

 Chg (%)  
More ...
Oncimmune Holdings PLC49.38 
FTSE 100 TR GBP10.62
 
Financials
201720182019
More ...
Income Statement
Turnover0.220.240.17
Operating Profit-5.27-6.37-8.59
Net Profit-5.02-6.34-8.01
Reported EPS-9.84-11.41-12.97
Balance Sheet
Current Assets5.6613.546.00
Non Current Assets0.750.873.43
Total Assets6.4114.419.43
Current Liabilities1.400.851.06
Total Liabilities---
Total Equity5.0013.567.87
Cash Flow
Operating Cash Flow-4.57-6.10-7.90
Net Change in Cash-5.097.87-7.59
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
04/05/2020PurchaseMr. Carsten Schroeder85.0018,00015,300.00
24/04/2020PurchaseDr. Adam Mark Hill MB PhD90.0011,11110,000.00
01/04/2020PurchaseDr. Adam Mark Hill MB PhD46.9021,32110,000.00
24/03/2020PurchaseMr. Meinhard Folkert Schmidt49.0018,0008,820.00

Company Profile

Oncimmune Holdings PLC is a cancer detection company engaged in developing and commercializing its proprietary EarlyCDT platform technology. Its product EarlyCDT-Lung is a simple blood test to aid the risk assessment and early detection of lung cancer.

Sector

Biotechnology

Index

FTSE AIM All-Share

Next Event 30/10/2020

Final Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-101.98
Op Mrgn-50.23
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive DirectorMr. Andrew Vaughan Unitt
Non-Executive Director, ChairmanMr. Meinhard Folkert Schmidt
Non-Executive Director, Deputy ChairmanMr. Timothy Brian Bunting
Executive Director, Chief Executive OfficerDr. Adam Mark Hill MB PhD
Non-Executive DirectorDr. To Cheung
Executive Director, Chief Financial OfficerMr. Matthew Hall
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2020 Morningstar. All rights reserved.